{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:46:47Z","timestamp":1793911607592,"version":"4.8.0"},"reference-count":225,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06527-x","type":"journal-article","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T08:48:54Z","timestamp":1746953334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The potential therapeutic approaches targeting gut health in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): a narrative review"],"prefix":"10.1186","volume":"23","author":[{"given":"Chou-Yi","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana Warid","family":"Maya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayada Ahmed","family":"Abass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhayveer","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal Kant","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Premkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2970-6309","authenticated-orcid":false,"given":"Mohsen","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,11]]},"reference":[{"issue":"20","key":"6527_CR1","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.3390\/jcm10204786","volume":"10","author":"US Deumer","year":"2021","unstructured":"Deumer US, Varesi A, Floris V, et al. Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): an overview. J Clin Med. 2021;10(20):4786. https:\/\/doi.org\/10.3390\/jcm10204786.","journal-title":"J Clin Med"},{"issue":"1","key":"6527_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12967-020-02269-0","volume":"18","author":"L Eun-Jin","year":"2020","unstructured":"Eun-Jin L, Ahn YC, Eun-Su J, Si-Woo L, Su-Hwa L, Chang-Gue S. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME). J Transl Med. 2020;18(1):100. https:\/\/doi.org\/10.1186\/s12967-020-02269-0.","journal-title":"J Transl Med"},{"issue":"11","key":"6527_CR3","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1016\/j.mayocp.2021.07.004","volume":"96","author":"L Bateman","year":"2021","unstructured":"Bateman L, Bested AC, Bonilla HF, et al. Myalgic encephalomyelitis\/chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clin Proc. 2021;96(11):2861\u201378. https:\/\/doi.org\/10.1016\/j.mayocp.2021.07.004.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"6527_CR4","doi-asserted-by":"publisher","DOI":"10.5812\/aapm.113629","volume":"11","author":"N Noor","year":"2021","unstructured":"Noor N, Urits I, Degueure A, et al. A comprehensive update of the current understanding of chronic fatigue syndrome. Anesth Pain Med. 2021;11(3): e113629. https:\/\/doi.org\/10.5812\/aapm.113629.","journal-title":"Anesth Pain Med"},{"issue":"1","key":"6527_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s40001-024-01747-1","volume":"29","author":"JH Wang","year":"2024","unstructured":"Wang JH, Choi Y, Lee JS, Hwang SJ, Gu J, Son CG. Clinical evidence of the link between gut microbiome and myalgic encephalomyelitis\/chronic fatigue syndrome: a retrospective review. Eur J Med Res. 2024;29(1):148. https:\/\/doi.org\/10.1186\/s40001-024-01747-1.","journal-title":"Eur J Med Res"},{"issue":"11","key":"6527_CR6","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3390\/nu16111545","volume":"16","author":"JM Jurek","year":"2024","unstructured":"Jurek JM, Castro-Marrero J. A narrative review on gut microbiome disturbances and microbial preparations in myalgic encephalomyelitis\/chronic fatigue syndrome: implications for long COVID. Nutrients. 2024;16(11):1545. https:\/\/doi.org\/10.3390\/nu16111545.","journal-title":"Nutrients"},{"issue":"2","key":"6527_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/jcm13020325","volume":"13","author":"KA Seton","year":"2024","unstructured":"Seton KA, Espejo-Oltra JA, Gim\u00e9nez-Orenga K, Haagmans R, Ramadan DJ, Mehlsen J. Advancing research and treatment: an overview of clinical trials in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and future perspectives. J Clin Med. 2024;13(2):325. https:\/\/doi.org\/10.3390\/jcm13020325.","journal-title":"J Clin Med"},{"issue":"10","key":"6527_CR8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.70616","volume":"16","author":"BS Graves","year":"2024","unstructured":"Graves BS, Patel M, Newgent H, et al. Chronic fatigue syndrome: diagnosis, treatment, and future direction. Cureus. 2024;16(10): e70616. https:\/\/doi.org\/10.7759\/cureus.70616.","journal-title":"Cureus"},{"key":"6527_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2024.103198","volume":"255","author":"T Liu","year":"2024","unstructured":"Liu T, Sun W, Guo S, et al. Research progress on pathogenesis of chronic fatigue syndrome and treatment of traditional Chinese and Western medicine. Auton Neurosci. 2024;255: 103198. https:\/\/doi.org\/10.1016\/j.autneu.2024.103198.","journal-title":"Auton Neurosci"},{"key":"6527_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.628741","volume":"12","author":"RS K\u00f6nig","year":"2022","unstructured":"K\u00f6nig RS, Albrich WC, Kahlert CR, et al. The gut microbiome in myalgic encephalomyelitis (ME)\/chronic fatigue syndrome (CFS). Front Immunol. 2022;12: 628741. https:\/\/doi.org\/10.3389\/fimmu.2021.628741.","journal-title":"Front Immunol"},{"issue":"21","key":"6527_CR11","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.3390\/jcm10215077","volume":"10","author":"A Varesi","year":"2021","unstructured":"Varesi A, Deumer US, Ananth S, Ricevuti G. The emerging role of gut microbiota in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): current evidence and potential therapeutic applications. J Clin Med. 2021;10(21):5077. https:\/\/doi.org\/10.3390\/jcm10215077.","journal-title":"J Clin Med"},{"issue":"1","key":"6527_CR12","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1038\/s41598-021-86425-6","volume":"11","author":"GF Lupo","year":"2021","unstructured":"Lupo GF, Rocchetti G, Lucini L, et al. Potential role of microbiome in chronic fatigue syndrome\/myalgic encephalomyelits (CFS\/ME). Sci Rep. 2021;11(1):7043. https:\/\/doi.org\/10.1038\/s41598-021-86425-6.","journal-title":"Sci Rep"},{"issue":"15","key":"6527_CR13","doi-asserted-by":"publisher","first-page":"1352744","DOI":"10.3389\/fimmu.2024.1352744","volume":"2024","author":"A Stallmach","year":"2024","unstructured":"Stallmach A, Quickert S, Puta C, Reuken PA. The gastrointestinal microbiota in the development of ME\/CFS: a critical view and potential perspectives. Front Immunol. 2024;2024(15):1352744. https:\/\/doi.org\/10.3389\/fimmu.2024.1352744.","journal-title":"Front Immunol"},{"key":"6527_CR14","doi-asserted-by":"publisher","first-page":"1253121","DOI":"10.3389\/fimmu.2023.1253121","volume":"14","author":"F Mart\u00edn","year":"2023","unstructured":"Mart\u00edn F, Blanco-Su\u00e1rez M, Zambrano P, et al. Increased gut permeability and bacterial translocation are associated with fibromyalgia and myalgic encephalomyelitis\/chronic fatigue syndrome: Implications for disease-related biomarker discovery. Front Immunol. 2023;14:1253121. https:\/\/doi.org\/10.3389\/fimmu.2023.1253121.","journal-title":"Front Immunol"},{"key":"6527_CR15","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3389\/fneur.2020.00826","volume":"11","author":"L Nacul","year":"2020","unstructured":"Nacul L, O\u2019Boyle S, Palla L, et al. How myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) progresses: the natural history of ME\/CFS. Front Neurol. 2020;11:826. https:\/\/doi.org\/10.3389\/fneur.2020.00826.","journal-title":"Front Neurol"},{"key":"6527_CR16","doi-asserted-by":"publisher","first-page":"1386607","DOI":"10.3389\/fimmu.2024.1386607","volume":"15","author":"HE Arron","year":"2024","unstructured":"Arron HE, Marsh BD, Kell DB, Khan MA, Jaeger BR, Pretorius E. Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: the biology of a neglected disease. Front Immunol. 2024;15:1386607. https:\/\/doi.org\/10.3389\/fimmu.2024.1386607.","journal-title":"Front Immunol"},{"issue":"3","key":"6527_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/diagnostics9030073","volume":"9","author":"E Sweetman","year":"2019","unstructured":"Sweetman E, Noble A, Edgar C, et al. Current research provides insight into the biological basis and diagnostic potential for myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). Diagnostics. 2019;9(3):73. https:\/\/doi.org\/10.3390\/diagnostics9030073.","journal-title":"Diagnostics"},{"issue":"3","key":"6527_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/diagnostics9030080","volume":"9","author":"D Missailidis","year":"2019","unstructured":"Missailidis D, Annesley SJ, Fisher PR. Pathological mechanisms underlying myalgic encephalomyelitis\/chronic fatigue syndrome. Diagnostics. 2019;9(3):80. https:\/\/doi.org\/10.3390\/diagnostics9030080.","journal-title":"Diagnostics"},{"issue":"1","key":"6527_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12967-024-05915-z","volume":"23","author":"K Huang","year":"2025","unstructured":"Huang K, Lidbury BA, Thomas N, Gooley PR, Armstrong CW. Machine learning and multi-omics in precision medicine for ME\/CFS. J Transl Med. 2025;23(1):68. https:\/\/doi.org\/10.1186\/s12967-024-05915-z.","journal-title":"J Transl Med"},{"issue":"4","key":"6527_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/02680930500131801","volume":"20","author":"M MacLure","year":"2005","unstructured":"MacLure M. \u2018Clarity bordering on stupidity\u2019: where\u2019s the quality in systematic review? J Educ Policy. 2005;20(4):393\u2013416. https:\/\/doi.org\/10.1080\/02680930500131801.","journal-title":"J Educ Policy"},{"issue":"1\u20133","key":"6527_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jad.2006.08.021","volume":"99","author":"M Maes","year":"2007","unstructured":"Maes M, Mihaylova I, Leunis JC. Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut\u2013intestinal permeability. J Affect Disord. 2007;99(1\u20133):237\u201340. https:\/\/doi.org\/10.1016\/j.jad.2006.08.021.","journal-title":"J Affect Disord"},{"issue":"4","key":"6527_CR22","first-page":"621","volume":"23","author":"JR Sheedy","year":"2009","unstructured":"Sheedy JR, Wettenhall RE, Scanlon D, et al. Increased d-lactic acid intestinal bacteria in patients with chronic fatigue syndrome. In Vivo. 2009;23(4):621\u20138.","journal-title":"In Vivo"},{"key":"6527_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.anaerobe.2013.06.002","volume":"22","author":"M Fr\u00e9mont","year":"2013","unstructured":"Fr\u00e9mont M, Coomans D, Massart S, De Meirleir K. High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis\/chronic fatigue syndrome patients. Anaerobe. 2013;22:50\u20136. https:\/\/doi.org\/10.1016\/j.anaerobe.2013.06.002.","journal-title":"Anaerobe"},{"issue":"12","key":"6527_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145453","volume":"10","author":"SK Shukla","year":"2015","unstructured":"Shukla SK, Cook D, Meyer J, et al. Changes in gut and plasma microbiome following exercise challenge in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). PLoS ONE. 2015;10(12): e0145453. https:\/\/doi.org\/10.1371\/journal.pone.0145453.","journal-title":"PLoS ONE"},{"key":"6527_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11306-016-1145-z","volume":"13","author":"CW Armstrong","year":"2017","unstructured":"Armstrong CW, McGregor NR, Lewis DP, Butt HL, Gooley PR. The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis\/chronic fatigue syndrome. Metabolomics. 2017;13:8. https:\/\/doi.org\/10.1007\/s11306-016-1145-z.","journal-title":"Metabolomics"},{"issue":"17","key":"6527_CR26","doi-asserted-by":"publisher","first-page":"720","DOI":"10.12659\/AJCR.900314","volume":"2016","author":"L Giloteaux","year":"2016","unstructured":"Giloteaux L, Hanson MR, Keller BA. A pair of identical twins discordant for myalgic encephalomyelitis\/chronic fatigue syndrome differ in physiological parameters and gut microbiome composition. Am J Case Rep. 2016;2016(17):720\u20139. https:\/\/doi.org\/10.12659\/AJCR.900314.","journal-title":"Am J Case Rep."},{"issue":"1","key":"6527_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40168-016-0171-4","volume":"4","author":"L Giloteaux","year":"2016","unstructured":"Giloteaux L, Goodrich JK, Walters WA, Levine SM, Ley RE, Hanson MR. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis\/chronic fatigue syndrome. Microbiome. 2016;4(1):30. https:\/\/doi.org\/10.1186\/s40168-016-0171-4.","journal-title":"Microbiome"},{"issue":"1","key":"6527_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40168-017-0261-y","volume":"5","author":"D Nagy-Szakal","year":"2017","unstructured":"Nagy-Szakal D, Williams BL, Mishra N, et al. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis\/chronic fatigue syndrome. Microbiome. 2017;5(1):44. https:\/\/doi.org\/10.1186\/s40168-017-0261-y.","journal-title":"Microbiome"},{"issue":"6","key":"6527_CR29","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.4282","volume":"2018","author":"AH Mandarano","year":"2018","unstructured":"Mandarano AH, Giloteaux L, Keller BA, Levine SM, Hanson MR. Eukaryotes in the gut microbiota in myalgic encephalomyelitis\/chronic fatigue syndrome. PeerJ. 2018;2018(6): e4282. https:\/\/doi.org\/10.7717\/peerj.4282.","journal-title":"PeerJ"},{"issue":"1","key":"6527_CR30","doi-asserted-by":"publisher","first-page":"19933","DOI":"10.1038\/s41598-020-77105-y","volume":"10","author":"T Kitami","year":"2020","unstructured":"Kitami T, Fukuda S, Kato T, et al. Deep phenotyping of myalgic encephalomyelitis\/chronic fatigue syndrome in Japanese population. Sci Rep. 2020;10(1):19933. https:\/\/doi.org\/10.1038\/s41598-020-77105-y.","journal-title":"Sci Rep"},{"key":"6527_CR31","doi-asserted-by":"publisher","first-page":"1190894","DOI":"10.3389\/fmicb.2023.1190894","volume":"14","author":"G He","year":"2023","unstructured":"He G, Cao Y, Ma H, et al. Causal effects between gut microbiome and myalgic encephalomyelitis\/chronic fatigue syndrome: a two-sample Mendelian randomization study. Front Microbiol. 2023;14:1190894. https:\/\/doi.org\/10.3389\/fmicb.2023.1190894.","journal-title":"Front Microbiol"},{"issue":"1","key":"6527_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13643-018-0909-0","volume":"7","author":"S Du Preez","year":"2018","unstructured":"Du Preez S, Corbitt M, Cabanas H, Eaton N, Staines D, Marshall-Gradisnik S. A systematic review of enteric dysbiosis in chronic fatigue syndrome\/myalgic encephalomyelitis. Syst Rev. 2018;7(1):241. https:\/\/doi.org\/10.1186\/s13643-018-0909-0.","journal-title":"Syst Rev"},{"issue":"6","key":"6527_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/jcm5060055","volume":"5","author":"N Navaneetharaja","year":"2016","unstructured":"Navaneetharaja N, Griffiths V, Wileman T, Carding SR. A role for the intestinal microbiota and virome in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)? J Clin Med. 2016;5(6):55. https:\/\/doi.org\/10.3390\/jcm5060055.","journal-title":"J Clin Med"},{"key":"6527_CR34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fped.2018.00373","volume":"6","author":"A Proal","year":"2018","unstructured":"Proal A, Marshall T. Myalgic encephalomyelitis\/chronic fatigue syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression, and immunity. Front Pediatr. 2018;6:373. https:\/\/doi.org\/10.3389\/fped.2018.00373.","journal-title":"Front Pediatr"},{"issue":"5","key":"6527_CR35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1042\/CS20171330","volume":"132","author":"F Newberry","year":"2018","unstructured":"Newberry F, Hsieh SY, Wileman T, Carding SR. Does the microbiome and virome contribute to myalgic encephalomyelitis\/chronic fatigue syndrome? Clin Sci. 2018;132(5):523\u201342. https:\/\/doi.org\/10.1042\/CS20171330.","journal-title":"Clin Sci"},{"issue":"1","key":"6527_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40168-016-0189-7","volume":"4","author":"M Estaki","year":"2016","unstructured":"Estaki M, Pither J, Baumeister P, et al. Cardiorespiratory fitness as a predictor of intestinal microbial diversity and distinct metagenomic functions. Microbiome. 2016;4(1):42. https:\/\/doi.org\/10.1186\/s40168-016-0189-7.","journal-title":"Microbiome"},{"issue":"2","key":"6527_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1055\/a-0802-9175","volume":"40","author":"JD Franklin","year":"2019","unstructured":"Franklin JD, Atkinson G, Atkinson JM, Batterham AM. Peak oxygen uptake in chronic fatigue syndrome\/myalgic encephalomyelitis: a meta-analysis. Int J Sports Med. 2019;40(2):77\u201387. https:\/\/doi.org\/10.1055\/a-0802-9175.","journal-title":"Int J Sports Med"},{"issue":"12","key":"6527_CR38","doi-asserted-by":"publisher","first-page":"10322","DOI":"10.3390\/ijms241210322","volume":"24","author":"M Montagnani","year":"2023","unstructured":"Montagnani M, Bottalico L, Potenza MA, et al. The crosstalk between gut microbiota and nervous system: a bidirectional interaction between microorganisms and metabolome. Int J Mol Sci. 2023;24(12):10322. https:\/\/doi.org\/10.3390\/ijms241210322.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"6527_CR39","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1136\/gutjnl-2018-316723","volume":"67","author":"PD Cani","year":"2018","unstructured":"Cani PD. Human gut microbiome: hopes, threats and promises. Gut. 2018;67(9):1716\u201325. https:\/\/doi.org\/10.1136\/gutjnl-2018-316723.","journal-title":"Gut"},{"issue":"2","key":"6527_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1042\/BIO03902010","volume":"39","author":"MR Hanson","year":"2017","unstructured":"Hanson MR, Giloteaux L. The gut microbiome in Myalgic Encephalomyelitis. Biochem. 2017;39(2):10\u20133. https:\/\/doi.org\/10.1042\/BIO03902010.","journal-title":"Biochem"},{"issue":"1","key":"6527_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12967-019-1888-1","volume":"17","author":"SY Tsai","year":"2019","unstructured":"Tsai SY, Chen HJ, Chen C, et al. Increased risk of chronic fatigue syndrome following psoriasis: a nationwide population-based cohort study. J Transl Med. 2019;17(1):55. https:\/\/doi.org\/10.1186\/s12967-019-1888-1.","journal-title":"J Transl Med"},{"issue":"3","key":"6527_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/diagnostics9030091","volume":"9","author":"M Cortes Rivera","year":"2019","unstructured":"Cortes Rivera M, Mastronardi C, Silva-Aldana CT, Arcos-Burgos M, Lidbury BA. Myalgic encephalomyelitis\/chronic fatigue syndrome: a comprehensive review. Diagnostics. 2019;9(3):91. https:\/\/doi.org\/10.3390\/diagnostics9030091.","journal-title":"Diagnostics"},{"key":"6527_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fendo.2020.00025","volume":"11","author":"YP Silva","year":"2020","unstructured":"Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol. 2020;11:25. https:\/\/doi.org\/10.3389\/fendo.2020.00025.","journal-title":"Front Endocrinol"},{"issue":"1","key":"6527_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12967-018-1392-z","volume":"16","author":"A Wallis","year":"2018","unstructured":"Wallis A, Ball M, Butt H, et al. Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis\/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons. J Transl Med. 2018;16(1):24. https:\/\/doi.org\/10.1186\/s12967-018-1392-z.","journal-title":"J Transl Med"},{"issue":"12","key":"6527_CR45","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1089\/jmf.2014.7000","volume":"17","author":"L Galland","year":"2014","unstructured":"Galland L. The gut microbiome and the brain. J Med Food. 2014;17(12):1261\u201372. https:\/\/doi.org\/10.1089\/jmf.2014.7000.","journal-title":"J Med Food"},{"issue":"9","key":"6527_CR46","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G Den Besten","year":"2013","unstructured":"Den Besten G, Van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54(9):2325\u201340. https:\/\/doi.org\/10.1194\/jlr.R036012.","journal-title":"J Lipid Res"},{"key":"6527_CR47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fped.2019.00012","volume":"7","author":"L Chu","year":"2019","unstructured":"Chu L, Valencia IJ, Garvert DW, Montoya JG. Onset patterns and course of myalgic encephalomyelitis\/chronic fatigue syndrome. Front Pediatr. 2019;7:12. https:\/\/doi.org\/10.3389\/fped.2019.00012.","journal-title":"Front Pediatr"},{"issue":"4","key":"6527_CR48","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","volume":"270","author":"BM Carruthers","year":"2011","unstructured":"Carruthers BM, van de Sande MI, De Meirleir KL, et al. Myalgic encephalomyelitis: international consensus criteria. J Intern Med. 2011;270(4):327\u201338. https:\/\/doi.org\/10.1111\/j.1365-2796.2011.02428.x.","journal-title":"J Intern Med"},{"issue":"3","key":"6527_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/nbm.1315","volume":"22","author":"SJ Mathew","year":"2009","unstructured":"Mathew SJ, Mao X, Keegan KA, et al. Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T 1H MRS imaging study. NMR Biomed. 2009;22(3):251\u20138. https:\/\/doi.org\/10.1002\/nbm.1315.","journal-title":"NMR Biomed"},{"issue":"7508","key":"6527_CR50","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nature13323","volume":"511","author":"A Bessede","year":"2014","unstructured":"Bessede A, Gargaro M, Pallotta MT, et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature. 2014;511(7508):184\u201390. https:\/\/doi.org\/10.1038\/nature13323.","journal-title":"Nature"},{"issue":"10","key":"6527_CR51","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1124\/dmd.115.064246","volume":"43","author":"TD Hubbard","year":"2015","unstructured":"Hubbard TD, Murray IA, Perdew GH. Indole and tryptophan metabolism: endogenous and dietary routes to Ah receptor activation. Drug Metab Dispos. 2015;43(10):1522\u201335. https:\/\/doi.org\/10.1124\/dmd.115.064246.","journal-title":"Drug Metab Dispos"},{"key":"6527_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4137\/IJTR.S10085","volume":"5","author":"A Blankfield","year":"2012","unstructured":"Blankfield A. A brief historic overview of clinical disorders associated with tryptophan: the relevance to chronic fatigue syndrome (CFS) and fibromyalgia (FM). Int J Tryptophan Res. 2012;5:27\u201332. https:\/\/doi.org\/10.4137\/IJTR.S10085.","journal-title":"Int J Tryptophan Res"},{"issue":"2","key":"6527_CR53","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","volume":"39","author":"T Zelante","year":"2013","unstructured":"Zelante T, Iannitti RG, Cunha C, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013;39(2):372\u201385. https:\/\/doi.org\/10.1016\/j.immuni.2013.08.003.","journal-title":"Immunity"},{"key":"6527_CR54","doi-asserted-by":"publisher","first-page":"16014","DOI":"10.1038\/npjbiofilms.2016.14","volume":"2","author":"A Korecka","year":"2016","unstructured":"Korecka A, Dona A, Lahiri S, et al. Bidirectional communication between the Aryl hydrocarbon Receptor (AhR) and the microbiome tunes host metabolism. NPJ Biofilms Microbiomes. 2016;2:16014. https:\/\/doi.org\/10.1038\/npjbiofilms.2016.14.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"20","key":"6527_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399406000068","volume":"8","author":"JP Ruddick","year":"2006","unstructured":"Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GA, Lowry CA. Tryptophan metabolism in the central nervous system: medical implications. Expert Rev Mol Med. 2006;8(20):1\u201327. https:\/\/doi.org\/10.1017\/S1462399406000068.","journal-title":"Expert Rev Mol Med"},{"issue":"5","key":"6527_CR56","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3892\/ijmm.2016.2750","volume":"38","author":"T Eleftheriadis","year":"2016","unstructured":"Eleftheriadis T, Pissas G, Sounidaki M, et al. Indoleamine 2, 3-dioxygenase, by degrading L-tryptophan, enhances carnitine palmitoyltransferase I activity and fatty acid oxidation, and exerts fatty acid-dependent effects in human alloreactive CD4+ T-cells. Int J Mol Med. 2016;38(5):605\u20131613. https:\/\/doi.org\/10.3892\/ijmm.2016.2750.","journal-title":"Int J Mol Med"},{"issue":"5","key":"6527_CR57","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3389\/fimmu.2014.00384","volume":"2014","author":"SV Schmidt","year":"2014","unstructured":"Schmidt SV, Schultze JL. New insights into IDO biology in bacterial and viral infections. Front Immunol. 2014;2014(5):384. https:\/\/doi.org\/10.3389\/fimmu.2014.00384.","journal-title":"Front Immunol"},{"issue":"3","key":"6527_CR58","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/diagnostics9030082","volume":"9","author":"AA Kashi","year":"2019","unstructured":"Kashi AA, Davis RW, Phair RD. The IDO metabolic trap hypothesis for the etiology of ME\/CFS. Diagnostics. 2019;9(3):82. https:\/\/doi.org\/10.3390\/diagnostics9030082.","journal-title":"Diagnostics"},{"issue":"5","key":"6527_CR59","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1039\/c9fo00123a","volume":"10","author":"M Chen","year":"2019","unstructured":"Chen M, Liu Y, Xiong S, et al. Dietary l-tryptophan alleviated LPS-induced intestinal barrier injury by regulating tight junctions in a Caco-2 cell monolayer model. Food Funct. 2019;10(5):2390\u20138. https:\/\/doi.org\/10.1039\/c9fo00123a.","journal-title":"Food Funct"},{"issue":"1","key":"6527_CR60","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/nu8010056","volume":"8","author":"TA Jenkins","year":"2016","unstructured":"Jenkins TA, Nguyen JC, Polglaze KE, Bertrand PP. Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis. Nutrients. 2016;8(1):56. https:\/\/doi.org\/10.3390\/nu8010056.","journal-title":"Nutrients"},{"issue":"8","key":"6527_CR61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fcimb.2018.00013","volume":"2018","author":"J Gao","year":"2018","unstructured":"Gao J, Xu K, Liu H, et al. Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front Cell Infect Microbiol. 2018;2018(8):13. https:\/\/doi.org\/10.3389\/fcimb.2018.00013.","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"6527_CR62","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41591-018-0060-4","volume":"24","author":"L Laurans","year":"2018","unstructured":"Laurans L, Venteclef N, Haddad Y, et al. Genetic deficiency of indoleamine 2, 3-dioxygenase promotes gut microbiota-mediated metabolic health. Nat Med. 2018;24(8):1113\u201320. https:\/\/doi.org\/10.1038\/s41591-018-0060-4.","journal-title":"Nat Med"},{"issue":"3","key":"6527_CR63","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.lungcan.2009.05.001","volume":"67","author":"Y Suzuki","year":"2010","unstructured":"Suzuki Y, Suda T, Furuhashi K, et al. Increased serum kynurenine\/tryptophan ratio correlates with disease progression in lung cancer. Lung Cancer. 2010;67(3):361\u20135. https:\/\/doi.org\/10.1016\/j.lungcan.2009.05.001.","journal-title":"Lung Cancer"},{"key":"6527_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1178646919868978","volume":"12","author":"AA Badawy","year":"2019","unstructured":"Badawy AA, Guillemin G. The plasma [kynurenine]\/[tryptophan] ratio and indoleamine 2, 3-dioxygenase: time for appraisal. Int J Tryptophan Res. 2019;12:1\u201310. https:\/\/doi.org\/10.1177\/1178646919868978.","journal-title":"Int J Tryptophan Res"},{"key":"6527_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/ijtr.s2097","volume":"2","author":"Y Chen","year":"2009","unstructured":"Chen Y, Guillemin GJ. Kynurenine pathway metabolites in humans: disease and healthy states. Int J Tryptophan Res. 2009;2:1\u201319. https:\/\/doi.org\/10.4137\/ijtr.s2097.","journal-title":"Int J Tryptophan Res"},{"issue":"12","key":"6527_CR66","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1128\/JVI.03678-13","volume":"88","author":"WL Liu","year":"2014","unstructured":"Liu WL, Lin YH, Xiao H, et al. Epstein-Barr virus infection induces indoleamine 2, 3-dioxygenase expression in human monocyte-derived macrophages through p38\/mitogen-activated protein kinase and NF-\u03baB pathways: impairment in T cell functions. J Virol. 2014;88(12):6660\u201371. https:\/\/doi.org\/10.1128\/JVI.03678-13.","journal-title":"J Virol"},{"issue":"7","key":"6527_CR67","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/ibd.21849","volume":"18","author":"NK Gupta","year":"2012","unstructured":"Gupta NK, Thaker AI, Kanuri N, et al. Serum analysis of tryptophan catabolism pathway: correlation with Crohn\u2019s disease activity. Inflamm Bowel Dis. 2012;18(7):1214\u201320. https:\/\/doi.org\/10.1002\/ibd.21849.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"6527_CR68","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","volume":"9","author":"HM Roager","year":"2018","unstructured":"Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun. 2018;9(1):3294. https:\/\/doi.org\/10.1038\/s41467-018-05470-4.","journal-title":"Nat Commun"},{"issue":"7568","key":"6527_CR69","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","volume":"333","author":"I Hickie","year":"2006","unstructured":"Hickie I, Davenport T, Wakefield D, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333(7568):575. https:\/\/doi.org\/10.1136\/bmj.38933.585764.AE.","journal-title":"BMJ"},{"key":"6527_CR70","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fimmu.2018.00229","volume":"9","author":"J Blomberg","year":"2018","unstructured":"Blomberg J, Gottfries CG, Elfaitouri A, Rizwan M, Ros\u00e9n A. Infection elicited autoimmunity and myalgic encephalomyelitis\/chronic fatigue syndrome: an explanatory model. Front Immunol. 2018;9:229. https:\/\/doi.org\/10.3389\/fimmu.2018.00229.","journal-title":"Front Immunol"},{"issue":"2","key":"6527_CR71","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jad.2013.03.029","volume":"150","author":"M Maes","year":"2013","unstructured":"Maes M, Ringel K, Kubera M, et al. In myalgic encephalomyelitis\/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation. J Affect Disord. 2013;150(2):223\u201330. https:\/\/doi.org\/10.1016\/j.jad.2013.03.029.","journal-title":"J Affect Disord"},{"issue":"5","key":"6527_CR72","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1034\/j.1600-0463.2003.1110504.x","volume":"111","author":"GL Nicolson","year":"2003","unstructured":"Nicolson GL, Gan R, Haier J. Multiple co-infections (mycoplasma, chlamydia, human herpes virus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms. APMIS. 2003;111(5):557\u201366. https:\/\/doi.org\/10.1034\/j.1600-0463.2003.1110504.x.","journal-title":"APMIS"},{"issue":"13","key":"6527_CR73","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1001\/archinte.163.13.1530","volume":"163","author":"M Reyes","year":"2003","unstructured":"Reyes M, Nisenbaum R, Hoaglin DC, et al. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med. 2003;163(13):1530\u20136. https:\/\/doi.org\/10.1001\/archinte.163.13.1530.","journal-title":"Arch Intern Med"},{"issue":"7","key":"6527_CR74","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1093\/jac\/dkw054","volume":"71","author":"W Schr\u00f6der","year":"2016","unstructured":"Schr\u00f6der W, Sommer H, Gladstone BP, et al. Gender differences in antibiotic prescribing in the community: a systematic review and meta-analysis. J Antimicrob Chemother. 2016;71(7):1800\u20136. https:\/\/doi.org\/10.1093\/jac\/dkw054.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"6527_CR75","doi-asserted-by":"publisher","first-page":"E319","DOI":"10.25011\/cim.v31i6.4917","volume":"31","author":"AA Thambirajah","year":"2008","unstructured":"Thambirajah AA, Sleigh K, Grant Stiver H, Chow AW. Differential heat shock protein responses to strenuous standardized exercise in chronic fatigue syndrome patients and matched healthy controls. Clin Invest Med. 2008;31(6):E319\u201327. https:\/\/doi.org\/10.25011\/cim.v31i6.4917.","journal-title":"Clin Invest Med"},{"issue":"9","key":"6527_CR76","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/nbm.2772","volume":"25","author":"DC Shungu","year":"2012","unstructured":"Shungu DC, Weiduschat N, Murrough JW, et al. Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed. 2012;25(9):1073\u201387.","journal-title":"NMR Biomed"},{"key":"6527_CR77","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1007\/s11306-015-0816-5","volume":"11","author":"CW Armstrong","year":"2015","unstructured":"Armstrong CW, McGregor NR, Lewis DP, Butt HL, Gooley PR. Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients. Metabolomics. 2015;11:1626\u201339. https:\/\/doi.org\/10.1007\/s11306-015-0816-5.","journal-title":"Metabolomics"},{"issue":"3","key":"6527_CR78","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.slsci.2015.10.001","volume":"8","author":"ML Jackson","year":"2015","unstructured":"Jackson ML, Butt H, Ball M, Lewis DP, Bruck D. Sleep quality and the treatment of intestinal microbiota imbalance in chronic fatigue syndrome: a pilot study. Sleep Sci. 2015;8(3):124\u201333. https:\/\/doi.org\/10.1016\/j.slsci.2015.10.001.","journal-title":"Sleep Sci"},{"issue":"9","key":"6527_CR79","doi-asserted-by":"publisher","first-page":"6806","DOI":"10.1007\/s12035-016-0170-2","volume":"54","author":"G Morris","year":"2017","unstructured":"Morris G, Anderson G, Maes M. Hypothalamic-pituitary-adrenal hypofunction in myalgic encephalomyelitis (ME)\/chronic fatigue syndrome (CFS) as a consequence of activated immune-inflammatory and oxidative and nitrosative pathways. Mol Neurobiol. 2017;54(9):6806\u201319. https:\/\/doi.org\/10.1007\/s12035-016-0170-2.","journal-title":"Mol Neurobiol"},{"key":"6527_CR80","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jad.2020.01.146","volume":"267","author":"A Herane-Vives","year":"2020","unstructured":"Herane-Vives A, Papadopoulos A, De Angel V, et al. Cortisol levels in chronic fatigue syndrome and atypical depression measured using hair and saliva specimens. J Affect Disord. 2020;267:307\u201314. https:\/\/doi.org\/10.1016\/j.jad.2020.01.146.","journal-title":"J Affect Disord"},{"issue":"8","key":"6527_CR81","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, Guarner F, Reid G, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506\u201314. https:\/\/doi.org\/10.1038\/nrgastro.2014.66.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"6527_CR82","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.3390\/microorganisms11092160","volume":"11","author":"A Colletti","year":"2023","unstructured":"Colletti A, Pellizzato M, Cicero AF. The possible role of probiotic supplementation in inflammation: a narrative review. Microorganisms. 2023;11(9):2160. https:\/\/doi.org\/10.3390\/microorganisms11092160.","journal-title":"Microorganisms"},{"issue":"5","key":"6527_CR83","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41591-019-0439-x","volume":"25","author":"J Suez","year":"2019","unstructured":"Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med. 2019;25(5):716\u201329. https:\/\/doi.org\/10.1038\/s41591-019-0439-x.","journal-title":"Nat Med"},{"key":"6527_CR84","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1475-2891-8-4","volume":"8","author":"A Sullivan","year":"2009","unstructured":"Sullivan A, Nord CE, Eveng\u00e5rd B. Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome. Nutr J. 2009;8:4. https:\/\/doi.org\/10.1186\/1475-2891-8-4.","journal-title":"Nutr J"},{"issue":"3","key":"6527_CR85","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s12602-018-9397-8","volume":"10","author":"M Corbitt","year":"2018","unstructured":"Corbitt M, Campagnolo N, Staines D, Marshall-Gradisnik S. A systematic review of probiotic interventions for gastrointestinal symptoms and irritable bowel syndrome in chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME). Probiotics Antimicrob Proteins. 2018;10(3):466\u201377. https:\/\/doi.org\/10.1007\/s12602-018-9397-8.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"6","key":"6527_CR86","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.cell.2018.08.047","volume":"174","author":"J Suez","year":"2018","unstructured":"Suez J, Zmora N, Zilberman-Schapira G, et al. Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell. 2018;174(6):1406\u201323. https:\/\/doi.org\/10.1016\/j.cell.2018.08.047.","journal-title":"Cell"},{"issue":"4","key":"6527_CR87","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4161\/gmic.25487","volume":"4","author":"D Groeger","year":"2013","unstructured":"Groeger D, O\u2019Mahony L, Murphy EF, et al. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes. 2013;4(4):325\u201339. https:\/\/doi.org\/10.4161\/gmic.25487.","journal-title":"Gut Microbes"},{"issue":"3","key":"6527_CR88","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/papt.12118","volume":"90","author":"J Daniels","year":"2017","unstructured":"Daniels J, Brigden A, Kacorova A. Anxiety and depression in chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME): examining the incidence of health anxiety in CFS\/ME. Psychol Psychother. 2017;90(3):502\u20139. https:\/\/doi.org\/10.1111\/papt.12118.","journal-title":"Psychol Psychother"},{"issue":"1","key":"6527_CR89","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12937-019-0475-x","volume":"18","author":"H Karakula-Juchnowicz","year":"2019","unstructured":"Karakula-Juchnowicz H, Rog J, Juchnowicz D, et al. The study evaluating the effect of probiotic supplementation on the mental status, inflammation, and intestinal barrier in major depressive disorder patients using gluten-free or gluten-containing diet (SANGUT study): a 12-week, randomized, double-blind, and placebo-controlled clinical study protocol. Nutr J. 2019;18(1):50. https:\/\/doi.org\/10.1186\/s12937-019-0475-x.","journal-title":"Nutr J"},{"issue":"2","key":"6527_CR90","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4088\/pcc.v10n0206","volume":"10","author":"JP Griffith","year":"2018","unstructured":"Griffith JP, Zarrouf FA. A systematic review of chronic fatigue syndrome: don\u2019t assume it\u2019s depression. Prim Care Companion J Clin Psychiatry. 2018;10(2):120\u20138. https:\/\/doi.org\/10.4088\/pcc.v10n0206.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"1","key":"6527_CR91","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1757-4749-1-6","volume":"1","author":"AV Rao","year":"2009","unstructured":"Rao AV, Bested AC, Beaulne TM, et al. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog. 2009;1(1):6. https:\/\/doi.org\/10.1186\/1757-4749-1-6.","journal-title":"Gut Pathog"},{"issue":"3","key":"6527_CR92","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/foods8030092","volume":"8","author":"D Davani-Davari","year":"2019","unstructured":"Davani-Davari D, Negahdaripour M, Karimzadeh I, et al. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods. 2019;8(3):92. https:\/\/doi.org\/10.3390\/foods8030092.","journal-title":"Foods"},{"issue":"4","key":"6527_CR93","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.3168\/jds.2016-11890","volume":"100","author":"G Boudry","year":"2017","unstructured":"Boudry G, Hamilton MK, Chichlowski M, et al. Bovine milk oligosaccharides decrease gut permeability and improve inflammation and microbial dysbiosis in diet-induced obese mice. J Dairy Sci. 2017;100(4):2471\u201381. https:\/\/doi.org\/10.3168\/jds.2016-11890.","journal-title":"J Dairy Sci"},{"issue":"15","key":"6527_CR94","doi-asserted-by":"publisher","first-page":"8603","DOI":"10.1111\/jcmm.15489","volume":"24","author":"T Yu","year":"2020","unstructured":"Yu T, Wang Y, Chen X, Xiong W, Tang Y, Lin L. Spirulina platensis alleviates chronic inflammation with modulation of gut microbiota and intestinal permeability in rats fed a high-fat diet. J Cell Mol Med. 2020;24(15):8603\u201313. https:\/\/doi.org\/10.1111\/jcmm.15489.","journal-title":"J Cell Mol Med"},{"key":"6527_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154767","volume":"119","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Lin T, Meng Y, et al. FOS\/GOS attenuates high-fat diet induced bone loss via reversing microbiota dysbiosis, high intestinal permeability and systemic inflammation in mice. Metabolism. 2021;119: 154767. https:\/\/doi.org\/10.1016\/j.metabol.2021.154767.","journal-title":"Metabolism"},{"issue":"8","key":"6527_CR96","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/gut.2008.165886","volume":"58","author":"PD Cani","year":"2009","unstructured":"Cani PD, Possemiers S, Van de Wiele T, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009;58(8):1091\u2013103. https:\/\/doi.org\/10.1136\/gut.2008.165886.","journal-title":"Gut"},{"issue":"6","key":"6527_CR97","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3390\/nu11061248","volume":"11","author":"JE Nettleton","year":"2019","unstructured":"Nettleton JE, Klancic T, Schick A, et al. Low-dose stevia (rebaudioside A) consumption perturbs gut microbiota and the mesolimbic dopamine reward system. Nutrients. 2019;11(6):1248. https:\/\/doi.org\/10.3390\/nu11061248.","journal-title":"Nutrients"},{"issue":"7484","key":"6527_CR98","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559\u201363. https:\/\/doi.org\/10.1038\/nature12820.","journal-title":"Nature"},{"issue":"8","key":"6527_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202000851","volume":"65","author":"M Snelson","year":"2021","unstructured":"Snelson M, Clarke RE, Nguyen TV, et al. Long term high protein diet feeding alters the microbiome and increases intestinal permeability, systemic inflammation and kidney injury in mice. Mol Nutr Food Res. 2021;65(8): e2000851. https:\/\/doi.org\/10.1002\/mnfr.202000851.","journal-title":"Mol Nutr Food Res"},{"issue":"6","key":"6527_CR100","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/nu10060761","volume":"10","author":"MH Do","year":"2018","unstructured":"Do MH, Lee E, Oh MJ, Kim Y, Park HY. High-glucose or-fructose diet cause changes of the gut microbiota and metabolic disorders in mice without body weight change. Nutrients. 2018;10(6):761. https:\/\/doi.org\/10.3390\/nu10060761.","journal-title":"Nutrients"},{"issue":"7","key":"6527_CR101","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3390\/nu11071662","volume":"11","author":"C Nilholm","year":"2019","unstructured":"Nilholm C, Roth B, Ohlsson B. A dietary intervention with reduction of starch and sucrose leads to reduced gastrointestinal and extra-intestinal symptoms in IBS patients. Nutrients. 2019;11(7):1662. https:\/\/doi.org\/10.3390\/nu11071662.","journal-title":"Nutrients"},{"issue":"1","key":"6527_CR102","doi-asserted-by":"publisher","first-page":"11955","DOI":"10.1038\/s41598-017-12109-9","volume":"7","author":"B Ott","year":"2017","unstructured":"Ott B, Skurk T, Hastreiter L, et al. Effect of caloric restriction on gut permeability, inflammation markers, and fecal microbiota in obese women. Sci Rep. 2017;7(1):11955. https:\/\/doi.org\/10.1038\/s41598-017-12109-9.","journal-title":"Sci Rep"},{"issue":"1","key":"6527_CR103","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/nu17010011","volume":"17","author":"N Carrasco-Querol","year":"2024","unstructured":"Carrasco-Querol N, Cabricano-Canga L, Bueno Hern\u00e1ndez N, et al. Effectiveness of the SYNCHRONIZE+ brief intervention in improving Mediterranean diet adherence, nutritional quality and intake pattern in persons with fibromyalgia and chronic fatigue syndrome. Nutrients. 2024;17(1):11. https:\/\/doi.org\/10.3390\/nu17010011.","journal-title":"Nutrients"},{"issue":"1","key":"6527_CR104","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/nu13010007","volume":"13","author":"G Merra","year":"2020","unstructured":"Merra G, Noce A, Marrone G, et al. Influence of mediterranean diet on human gut microbiota. Nutrients. 2020;13(1):7. https:\/\/doi.org\/10.3390\/nu13010007.","journal-title":"Nutrients"},{"issue":"4","key":"6527_CR105","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/ncp.10233","volume":"34","author":"TL Kortlever","year":"2019","unstructured":"Kortlever TL, Ten Bokkel HS, Offereins M, et al. Low-FODMAP diet is associated with improved quality of life in IBS patients\u2014a prospective observational study. Nutr Clin Pract. 2019;34(4):623\u201330. https:\/\/doi.org\/10.1002\/ncp.10233.","journal-title":"Nutr Clin Pract"},{"issue":"4","key":"6527_CR106","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000565","volume":"6","author":"JN Brenton","year":"2019","unstructured":"Brenton JN, Banwell B, Bergqvist AC, et al. Goldman, Pilot study of a ketogenic diet in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm. 2019;6(4): e565. https:\/\/doi.org\/10.1212\/NXI.0000000000000565.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"8","key":"6527_CR107","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/mds.27390","volume":"33","author":"MC Phillips","year":"2018","unstructured":"Phillips MC, Murtagh DK, Gilbertson LJ, Asztely FJ, Lynch CD. Low-fat versus ketogenic diet in Parkinson\u2019s disease: a pilot randomized controlled trial. Mov Disord. 2018;33(8):1306\u201314. https:\/\/doi.org\/10.1002\/mds.27390.","journal-title":"Mov Disord"},{"issue":"1","key":"6527_CR108","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s12885-018-4353-2","volume":"18","author":"SP Bauersfeld","year":"2018","unstructured":"Bauersfeld SP, Kessler CS, Wischnewsky M, et al. The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study. BMC Cancer. 2018;18(1):476. https:\/\/doi.org\/10.1186\/s12885-018-4353-2.","journal-title":"BMC Cancer"},{"issue":"6","key":"6527_CR109","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.cell.2020.04.027","volume":"181","author":"QY Ang","year":"2020","unstructured":"Ang QY, Alexander M, Newman JC, et al. Ketogenic diets alter the gut microbiome resulting in decreased intestinal Th17 cells. Cell. 2020;181(6):1263-1275.e16. https:\/\/doi.org\/10.1016\/j.cell.2020.04.027.","journal-title":"Cell"},{"issue":"5","key":"6527_CR110","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.mehy.2015.08.013","volume":"85","author":"C Craig","year":"2015","unstructured":"Craig C. Mitoprotective dietary approaches for myalgic encephalomyelitis\/chronic fatigue syndrome: caloric restriction, fasting, and ketogenic diets. Med Hypotheses. 2015;85(5):690\u20133. https:\/\/doi.org\/10.1016\/j.mehy.2015.08.013.","journal-title":"Med Hypotheses"},{"issue":"2","key":"6527_CR111","doi-asserted-by":"publisher","first-page":"33","DOI":"10.31254\/sportmed.3202","volume":"3","author":"J Cossington","year":"2019","unstructured":"Cossington J, Coe DS, Liu Y, Dawes H. Potential benefits of a ketogenic diet to improve response and recovery from physical exertion in people with Myalgic encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS): a feasibility study. Int J Sport Exerc Health Res. 2019;3(2):33\u20139. https:\/\/doi.org\/10.31254\/sportmed.3202.","journal-title":"Int J Sport Exerc Health Res."},{"key":"6527_CR112","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1475-2891-9-55","volume":"9","author":"T Sathyapalan","year":"2010","unstructured":"Sathyapalan T, Beckett S, Rigby AS, Mellor DD, Atkin SL. High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome. Nutr J. 2010;9:55. https:\/\/doi.org\/10.1186\/1475-2891-9-55.","journal-title":"Nutr J"},{"issue":"3","key":"6527_CR113","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/jhn.12435","volume":"30","author":"N Campagnolo","year":"2017","unstructured":"Campagnolo N, Johnston S, Collatz A, Staines D, Marshall-Gradisnik S. Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome\/myalgic encephalomyelitis: a systematic review. J Hum Nutr Diet. 2017;30(3):247\u201359. https:\/\/doi.org\/10.1111\/jhn.12435.","journal-title":"J Hum Nutr Diet"},{"key":"6527_CR114","doi-asserted-by":"publisher","first-page":"11276","DOI":"10.1038\/srep11276","volume":"5","author":"K Kaliannan","year":"2015","unstructured":"Kaliannan K, Wang B, Li XY, Kim KJ, Kang JX. A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia. Sci Rep. 2015;5:11276. https:\/\/doi.org\/10.1038\/srep11276.","journal-title":"Sci Rep"},{"issue":"4","key":"6527_CR115","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.plefa.2003.12.015","volume":"70","author":"BK Puri","year":"2004","unstructured":"Puri BK. The use of eicosapentaenoic acid in the treatment of chronic fatigue syndrome. Prostaglandins Leukot Essent Fatty Acids. 2004;70(4):399\u2013401. https:\/\/doi.org\/10.1016\/j.plefa.2003.12.015.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"2","key":"6527_CR116","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/jcp.2006.042424","volume":"60","author":"BK Puri","year":"2007","unstructured":"Puri BK. Long-chain polyunsaturated fatty acids and the pathophysiology of myalgic encephalomyelitis (chronic fatigue syndrome). J Clin Pathol. 2007;60(2):122\u20134. https:\/\/doi.org\/10.1136\/jcp.2006.042424.","journal-title":"J Clin Pathol"},{"issue":"1","key":"6527_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086117","volume":"9","author":"JH Wang","year":"2014","unstructured":"Wang JH, Bose S, Kim GC, et al. Flos Lonicera ameliorates obesity and associated endotoxemia in rats through modulation of gut permeability and intestinal microbiota. PLoS ONE. 2014;9(1): e86117. https:\/\/doi.org\/10.1371\/journal.pone.0086117.","journal-title":"PLoS ONE"},{"key":"6527_CR118","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijbiomac.2017.02.074","volume":"99","author":"S Wang","year":"2017","unstructured":"Wang S, Li Q, Zang Y, et al. Apple Polysaccharide inhibits microbial dysbiosis and chronic inflammation and modulates gut permeability in HFD-fed rats. Int J Biol Macromol. 2017;99:282\u201392. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.02.074.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"6527_CR119","doi-asserted-by":"publisher","first-page":"5544","DOI":"10.1038\/s41598-020-62506-w","volume":"10","author":"S Fujisaka","year":"2020","unstructured":"Fujisaka S, Usui I, Nawaz A, et al. Bofutsushosan improves gut barrier function with a bloom of Akkermansia muciniphila and improves glucose metabolism in mice with diet-induced obesity. Sci Rep. 2020;10(1):5544. https:\/\/doi.org\/10.1038\/s41598-020-62506-w.","journal-title":"Sci Rep"},{"key":"6527_CR120","doi-asserted-by":"publisher","first-page":"9140896","DOI":"10.1155\/2018\/9140896","volume":"2018","author":"X Wang","year":"2018","unstructured":"Wang X, Qu Y, Zhang Y, et al. Antifatigue potential activity of Sarcodon imbricatus in acute excise-treated and chronic fatigue syndrome in mice via regulation of Nrf2-mediated oxidative stress. Oxid Med Cell Longev. 2018;2018:9140896. https:\/\/doi.org\/10.1155\/2018\/9140896.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"6527_CR121","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/13880209.2021.1900878","volume":"59","author":"DA Kwon","year":"2021","unstructured":"Kwon DA, Kim YS, Kim SK, Baek SH, Kim HK, Lee HS. Antioxidant and antifatigue effect of a standardized fraction (HemoHIM) from Angelica gigas, Cnidium officinale, and Paeonia lactiflora. Pharm Biol. 2021;59(1):391\u2013400. https:\/\/doi.org\/10.1080\/13880209.2021.1900878.","journal-title":"Pharm Biol"},{"issue":"4","key":"6527_CR122","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s12272-013-0235-y","volume":"37","author":"J Wang","year":"2014","unstructured":"Wang J, Sun C, Zheng Y, Pan H, Zhou Y, Fan Y. The effective mechanism of the polysaccharides from Panax ginseng on chronic fatigue syndrome. Arch Pharm Res. 2014;37(4):530\u20138. https:\/\/doi.org\/10.1007\/s12272-013-0235-y.","journal-title":"Arch Pharm Res"},{"key":"6527_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.658630","volume":"8","author":"J Kan","year":"2021","unstructured":"Kan J, Cheng J, Hu C, et al. A botanical product containing Cistanche and Ginkgo extracts potentially improves chronic fatigue syndrome symptoms in adults: a randomized, double-blind, and placebo-controlled study. Front Nutr. 2021;8: 658630. https:\/\/doi.org\/10.3389\/fnut.2021.658630.","journal-title":"Front Nutr"},{"issue":"1","key":"6527_CR124","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s12967-023-04250-z","volume":"21","author":"H Luo","year":"2023","unstructured":"Luo H, Gong R, Zheng R, et al. Dose\u2013effect of long-snake-like moxibustion for chronic fatigue syndrome: a randomized controlled trial. J Transl Med. 2023;21(1):430. https:\/\/doi.org\/10.1186\/s12967-023-04250-z.","journal-title":"J Transl Med"},{"key":"6527_CR125","doi-asserted-by":"publisher","DOI":"10.1177\/2164957X221079790","author":"J Yang","year":"2022","unstructured":"Yang J, Shin KM, Abu Dabrh AM, et al. Ginseng for the treatment of chronic fatigue syndrome: a systematic review of clinical studies. Glob Adv Health Med. 2022. https:\/\/doi.org\/10.1177\/2164957X221079790.","journal-title":"Glob Adv Health Med."},{"issue":"5","key":"6527_CR126","doi-asserted-by":"publisher","first-page":"625","DOI":"10.4088\/jcp.v66n0513","volume":"66","author":"SE Bentler","year":"2005","unstructured":"Bentler SE, Hartz AJ, Kuhn EM. Prospective observational study of treatments for unexplained chronic fatigue. J Clin Psychiatry. 2005;66(5):625\u201332. https:\/\/doi.org\/10.4088\/jcp.v66n0513.","journal-title":"J Clin Psychiatry"},{"key":"6527_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2019.102246","volume":"48","author":"WS Sung","year":"2020","unstructured":"Sung WS, Kang HR, Jung CY, Park SS, Lee SH, Kim EJ. Efficacy of Korean red ginseng (Panax ginseng) for middle-aged and moderate level of chronic fatigue patients: a randomized, double-blind, placebo-controlled trial. Complement Ther Med. 2020;48: 102246. https:\/\/doi.org\/10.1016\/j.ctim.2019.102246.","journal-title":"Complement Ther Med"},{"issue":"1","key":"6527_CR128","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/ph15010043","volume":"15","author":"J Teitelbaum","year":"2021","unstructured":"Teitelbaum J, Goudie S. An open-label, pilot trial of HRG80\u2122 red ginseng in chronic fatigue syndrome, fibromyalgia, and post-viral fatigue. Pharmaceuticals. 2021;15(1):43. https:\/\/doi.org\/10.3390\/ph15010043.","journal-title":"Pharmaceuticals"},{"issue":"3","key":"6527_CR129","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3390\/nu17030475","volume":"17","author":"MC Dorczok","year":"2025","unstructured":"Dorczok MC, Mittmann G, Mossaheb N, et al. Dietary supplementation for fatigue symptoms in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)\u2014a systematic review. Nutrients. 2025;17(3):475. https:\/\/doi.org\/10.3390\/nu17030475.","journal-title":"Nutrients"},{"issue":"10\u201312","key":"6527_CR130","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1089\/ars.2022.0018","volume":"36","author":"J Castro-Marrero","year":"2022","unstructured":"Castro-Marrero J, Domingo JC, Cordobilla B, et al. Does coenzyme Q10 plus selenium supplementation ameliorate clinical outcomes by modulating oxidative stress and inflammation in individuals with myalgic encephalomyelitis\/chronic fatigue syndrome? Antioxid Redox Signal. 2022;36(10\u201312):729\u201339. https:\/\/doi.org\/10.1089\/ars.2022.0018.","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"6527_CR131","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.3390\/nu13082658","volume":"13","author":"J Castro-Marrero","year":"2021","unstructured":"Castro-Marrero J, Segundo MJ, Lacasa M, Martinez-Martinez A, Senta\u00f1es RS, Alegre-Martin J. Effect of dietary coenzyme Q10 plus NADH supplementation on fatigue perception and health-related quality of life in individuals with myalgic encephalomyelitis\/chronic fatigue syndrome: a prospective, randomized, double-blind, placebo-controlled trial. Nutrients. 2021;13(8):2658. https:\/\/doi.org\/10.3390\/nu13082658.","journal-title":"Nutrients"},{"issue":"2","key":"6527_CR132","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1081-1206(10)62595-1","volume":"82","author":"LM Forsyth","year":"1999","unstructured":"Forsyth LM, Preuss HG, MacDowell AL, Chiazze L Jr, Birkmayer GD, Bellanti JA. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol. 1999;82(2):185\u201391. https:\/\/doi.org\/10.1016\/S1081-1206(10)62595-1.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"6527_CR133","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1034\/j.1601-5215.2003.00045.x","volume":"15","author":"RK Kurup","year":"2003","unstructured":"Kurup RK, Kurup PA. Isoprenoid pathway dysfunction in chronic fatigue syndrome. Acta Neuropsychiatr. 2003;15(5):266\u201373. https:\/\/doi.org\/10.1034\/j.1601-5215.2003.00045.x.","journal-title":"Acta Neuropsychiatr"},{"issue":"4","key":"6527_CR134","first-page":"470","volume":"30","author":"M Maes","year":"2009","unstructured":"Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Coenzyme Q10 deficiency in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME\/CFS due to cardiovascular disorder. Neuroendocrinol Lett. 2009;30(4):470\u20136.","journal-title":"Neuroendocrinol Lett"},{"issue":"15","key":"6527_CR135","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1089\/ars.2013.5346","volume":"19","author":"J Castro-Marrero","year":"2013","unstructured":"Castro-Marrero J, Cordero MD, S\u00e1ez-Francas N, et al. Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia? Antioxid Redox Signal. 2013;19(15):1855\u201360. https:\/\/doi.org\/10.1089\/ars.2013.5346.","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"6527_CR136","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3390\/ph16050686","volume":"16","author":"AY Ivanova","year":"2023","unstructured":"Ivanova AY, Shirokov IV, Toshchakov SV, et al. Effects of coenzyme Q10 on the biomarkers (Hydrogen, Methane, SCFA and TMA) and composition of the gut microbiome in rats. Pharmaceuticals. 2023;16(5):686. https:\/\/doi.org\/10.3390\/ph16050686.","journal-title":"Pharmaceuticals"},{"key":"6527_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.883251","volume":"13","author":"I Tsai","year":"2022","unstructured":"Tsai I, Hsu CW, Chang CH, Tseng PT, Chang KV. Effectiveness of coenzyme Q10 supplementation for reducing fatigue: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2022;13: 883251. https:\/\/doi.org\/10.3389\/fphar.2022.883251.","journal-title":"Front Pharmacol"},{"issue":"7","key":"6527_CR138","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3390\/antiox10071010","volume":"10","author":"J Castro-Marrero","year":"2021","unstructured":"Castro-Marrero J, Zaragoz\u00e1 MC, L\u00f3pez-V\u00edlchez I, et al. Effect of melatonin plus zinc supplementation on fatigue perception in myalgic encephalomyelitis\/chronic fatigue syndrome: a randomized, double-blind, placebo-controlled trial. Antioxidants. 2021;10(7):1010. https:\/\/doi.org\/10.3390\/antiox10071010.","journal-title":"Antioxidants"},{"issue":"1","key":"6527_CR139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008208","volume":"16","author":"EE Putnam","year":"2020","unstructured":"Putnam EE, Goodman AL. B vitamin acquisition by gut commensal bacteria. PLoS Pathog. 2020;16(1): e1008208. https:\/\/doi.org\/10.1371\/journal.ppat.1008208.","journal-title":"PLoS Pathog"},{"issue":"4","key":"6527_CR140","doi-asserted-by":"publisher","first-page":"e00886","DOI":"10.1128\/mBio.00886-20","volume":"11","author":"EC Soto-Martin","year":"2020","unstructured":"Soto-Martin EC, Warnke I, Farquharson FM, et al. Vitamin biosynthesis by human gut butyrate-producing bacteria and cross-feeding in synthetic microbial communities. MBio. 2020;11(4):e00886-e920. https:\/\/doi.org\/10.1128\/mBio.00886-20.","journal-title":"MBio"},{"issue":"5","key":"6527_CR141","doi-asserted-by":"publisher","first-page":"e00116-17","DOI":"10.1128\/mSystems.00116-17","volume":"2","author":"ZA Costliow","year":"2017","unstructured":"Costliow ZA, Degnan PH. Thiamine acquisition strategies impact metabolism and competition in the gut microbe Bacteroides thetaiotaomicron. mSystems. 2017;2(5):e00116-17. https:\/\/doi.org\/10.1128\/mSystems.00116-17.","journal-title":"mSystems."},{"issue":"11","key":"6527_CR142","first-page":"907","volume":"40","author":"S Kreijkamp-Kaspers","year":"2011","unstructured":"Kreijkamp-Kaspers S, Brenu EW, Marshall S, Staines D, Van Driel ML. Treating chronic fatigue syndrome: a study into the scientific evidence for pharmacological treatments. Aust Fam Physician. 2011;40(11):907\u201312.","journal-title":"Aust Fam Physician"},{"key":"6527_CR143","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12875-016-0493-0","volume":"17","author":"AS Bansal","year":"2016","unstructured":"Bansal AS. Investigating unexplained fatigue in general practice with a particular focus on CFS\/ME. BMC Fam Pract. 2016;17:81. https:\/\/doi.org\/10.1186\/s12875-016-0493-0.","journal-title":"BMC Fam Pract"},{"key":"6527_CR144","doi-asserted-by":"publisher","first-page":"1358404","DOI":"10.3389\/fendo.2024.1358404","volume":"15","author":"T Raij","year":"2024","unstructured":"Raij T, Raij K. Association between fatigue, peripheral serotonin, and L-carnitine in hypothyroidism and in chronic fatigue syndrome. Front Endocrinol. 2024;15:1358404. https:\/\/doi.org\/10.3389\/fendo.2024.1358404.","journal-title":"Front Endocrinol"},{"issue":"4","key":"6527_CR145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176631","volume":"12","author":"ML Joustra","year":"2017","unstructured":"Joustra ML, Minovic I, Janssens KA, Bakker SJ, Rosmalen JG. Vitamin and mineral status in chronic fatigue syndrome and fibromyalgia syndrome: a systematic review and meta-analysis. PLoS ONE. 2017;12(4): e0176631. https:\/\/doi.org\/10.1371\/journal.pone.0176631.","journal-title":"PLoS ONE"},{"issue":"3","key":"6527_CR146","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s0304-3940(02)01058-3","volume":"335","author":"J Vecchiet","year":"2003","unstructured":"Vecchiet J, Cipollone F, Falasca K, et al. Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett. 2003;335(3):151\u20134. https:\/\/doi.org\/10.1016\/s0304-3940(02)01058-3.","journal-title":"Neurosci Lett"},{"issue":"4","key":"6527_CR147","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/1753-6405.12670","volume":"41","author":"K Jones","year":"2017","unstructured":"Jones K, Probst Y. Role of dietary modification in alleviating chronic fatigue syndrome symptoms: a systematic review. Aust N Z J Public Health. 2017;41(4):338\u201344. https:\/\/doi.org\/10.1111\/1753-6405.12670.","journal-title":"Aust N Z J Public Health"},{"key":"6527_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105465","volume":"165","author":"PL Toogood","year":"2021","unstructured":"Toogood PL, Clauw DJ, Phadke S, Hoffman D. Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): where will the drugs come from? Pharmacol Res. 2021;165: 105465. https:\/\/doi.org\/10.1016\/j.phrs.2021.105465.","journal-title":"Pharmacol Res"},{"key":"6527_CR149","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.574533","volume":"11","author":"P Tan","year":"2020","unstructured":"Tan P, Li X, Shen J, Feng Q. Fecal microbiota transplantation for the treatment of inflammatory bowel disease: an update. Front Pharmacol. 2020;11: 574533. https:\/\/doi.org\/10.3389\/fphar.2020.574533.","journal-title":"Front Pharmacol"},{"issue":"1","key":"6527_CR150","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/jama.2017.6466","volume":"318","author":"A Gupta","year":"2017","unstructured":"Gupta A, Khanna S. Fecal microbiota transplantation. JAMA. 2017;318(1):102. https:\/\/doi.org\/10.1001\/jama.2017.6466.","journal-title":"JAMA"},{"issue":"3","key":"6527_CR151","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12325-018-0673-5","volume":"35","author":"BK Rodi\u00f1o-Janeiro","year":"2018","unstructured":"Rodi\u00f1o-Janeiro BK, Vicario M, Alonso-Cotoner C, Pascua-Garc\u00eda R, Santos J. A review of microbiota and irritable bowel syndrome: future in therapiesm. Adv Ther. 2018;35(3):289\u2013310. https:\/\/doi.org\/10.1007\/s12325-018-0673-5.","journal-title":"Adv Ther"},{"issue":"26","key":"6527_CR152","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1056\/NEJMc1803103","volume":"378","author":"FE Juul","year":"2018","unstructured":"Juul FE, Garborg K, Bretthauer M, et al. Fecal microbiota transplantation for primary Clostridium difficile infection. N Engl J Med. 2018;378(26):2535\u20136. https:\/\/doi.org\/10.1056\/NEJMc1803103.","journal-title":"N Engl J Med"},{"issue":"4","key":"6527_CR153","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/ajg.2013.4","volume":"108","author":"CM Surawicz","year":"2014","unstructured":"Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention ofclostridium difficileInfections. Am J Gastroenterol. 2014;108(4):478\u201398. https:\/\/doi.org\/10.1038\/ajg.2013.4.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"6527_CR154","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/biology10050447","volume":"10","author":"SD Malnick","year":"2021","unstructured":"Malnick SD, Fisher D, Somin M, Neuman MG. Treating the metabolic syndrome by fecal transplantation\u2014current status. Biology. 2021;10(5):447. https:\/\/doi.org\/10.3390\/biology10050447.","journal-title":"Biology"},{"issue":"3","key":"6527_CR155","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5946\/ce.2015.117","volume":"49","author":"HH Choi","year":"2016","unstructured":"Choi HH, Cho YS. Fecal microbiota transplantation: current applications, effectiveness, and future perspectives. Clin Endosc. 2016;49(3):257\u201365. https:\/\/doi.org\/10.5946\/ce.2015.117.","journal-title":"Clin Endosc"},{"issue":"8","key":"6527_CR156","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/ijc.32003","volume":"145","author":"D Chen","year":"2019","unstructured":"Chen D, Wu J, Jin D, Wang B, Cao H. Fecal microbiota transplantation in cancer management: current status and perspectives. Int J Cancer. 2019;145(8):2021\u201331. https:\/\/doi.org\/10.1002\/ijc.32003.","journal-title":"Int J Cancer"},{"issue":"2","key":"6527_CR157","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","volume":"69","author":"MS Kim","year":"2020","unstructured":"Kim MS, Kim Y, Choi H, et al. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model. Gut. 2020;69(2):283\u201394. https:\/\/doi.org\/10.1136\/gutjnl-2018-317431.","journal-title":"Gut"},{"issue":"1","key":"6527_CR158","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3748\/wjg.v21.i1.102","volume":"21","author":"MQ Xu","year":"2015","unstructured":"Xu MQ, Cao HL, Wang WQ, et al. Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J Gastroenterol. 2015;21(1):102\u201311. https:\/\/doi.org\/10.3748\/wjg.v21.i1.102.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"6527_CR159","doi-asserted-by":"publisher","first-page":"231","DOI":"10.9758\/cpn.2016.14.3.231","volume":"14","author":"A Evrensel","year":"2016","unstructured":"Evrensel A, Ceylan ME. Fecal microbiota transplantation and its usage in neuropsychiatric disorders. Clin Psychopharmacol Neurosci. 2016;14(3):231\u20137. https:\/\/doi.org\/10.9758\/cpn.2016.14.3.231.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"3","key":"6527_CR160","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3316\/informit.119626231492520","volume":"31","author":"TJ Borody","year":"2012","unstructured":"Borody TJ, Nowak A, Finlayson S. The GI microbiome and its role in chronic fatigue syndrome: a summary of bacteriotherapy. J Australas Coll Nutr Environ Med. 2012;31(3):3\u20138. https:\/\/doi.org\/10.3316\/informit.119626231492520.","journal-title":"J Australas Coll Nutr Environ Med"},{"key":"6527_CR161","doi-asserted-by":"publisher","first-page":"100061","DOI":"10.1016\/j.humic.2019.100061","volume":"13","author":"JN Kenyon","year":"2019","unstructured":"Kenyon JN, Coe S, Izadi H. A retrospective outcome study of 42 patients with Chronic Fatigue Syndrome, 30 of whom had Irritable Bowel Syndrome. Half were treated with oral approaches, and half were treated with Faecal Microbiome Transplantation. Hum Microbiome J. 2019;13:100061. https:\/\/doi.org\/10.1016\/j.humic.2019.100061.","journal-title":"Hum Microbiome J."},{"issue":"1","key":"6527_CR162","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3748\/wjg.v24.i1.5","volume":"24","author":"ZH Shen","year":"2018","unstructured":"Shen ZH, Zhu CX, Quan YS, et al. Relationship between intestinal microbiota and ulcerative colitis: mechanisms and clinical application of probiotics and fecal microbiota transplantation. World J Gastroenterol. 2018;24(1):5\u201314. https:\/\/doi.org\/10.3748\/wjg.v24.i1.5.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"6527_CR163","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12967-023-04227-y","volume":"21","author":"T Salonen","year":"2023","unstructured":"Salonen T, Jokinen E, Satokari R, Lahtinen P. Randomized, double-blinded, placebo-controlled pilot study: efficacy of faecal microbiota transplantation on chronic fatigue syndrome. J Transl Med. 2023;21(1):513. https:\/\/doi.org\/10.1186\/s12967-023-04227-y.","journal-title":"J Transl Med"},{"key":"6527_CR164","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.coph.2018.08.012","volume":"43","author":"M Schmulson","year":"2018","unstructured":"Schmulson M, Bashashati M. Fecal microbiota transfer for bowel disorders: efficacy or hype? Curr Opin Pharmacol. 2018;43:72\u201380. https:\/\/doi.org\/10.1016\/j.coph.2018.08.012.","journal-title":"Curr Opin Pharmacol"},{"issue":"4","key":"6527_CR165","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/14712598.2020.1733964","volume":"20","author":"LR Lopetuso","year":"2020","unstructured":"Lopetuso LR, Ianiro G, Allegretti JR, et al. Fecal transplantation for ulcerative colitis: current evidence and future applications. Expert Opin Biol Ther. 2020;20(4):343\u201351. https:\/\/doi.org\/10.1080\/14712598.2020.1733964.","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"6527_CR166","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1053\/j.gastro.2014.01.050","volume":"146","author":"F Shanahan","year":"2014","unstructured":"Shanahan F, Quigley EM. Manipulation of the microbiota for treatment of IBS and IBD\u2014challenges and controversies. Gastroenterology. 2014;146(6):1554\u201363. https:\/\/doi.org\/10.1053\/j.gastro.2014.01.050.","journal-title":"Gastroenterology"},{"issue":"11","key":"6527_CR167","doi-asserted-by":"publisher","first-page":"CD012774","DOI":"10.1002\/14651858.CD012774.pub2","volume":"11","author":"A Imdad","year":"2018","unstructured":"Imdad A, Pandit NG, Zaman M, et al. Fecal transplantation for treatment of inflammatory bowel disease. Cochrane Database Syst Rev. 2018;11(11):CD012774. https:\/\/doi.org\/10.1002\/14651858.CD012774.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"6527_CR168","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/MOG.0b013e32835a4b3e","volume":"29","author":"OC Aroniadis","year":"2013","unstructured":"Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol. 2013;29(1):79\u201384. https:\/\/doi.org\/10.1097\/MOG.0b013e32835a4b3e.","journal-title":"Curr Opin Gastroenterol"},{"key":"6527_CR169","doi-asserted-by":"publisher","first-page":"175628481983689","DOI":"10.1177\/1756284819836893","volume":"12","author":"AN Levy","year":"2019","unstructured":"Levy AN, Allegretti JR. Insights into the role of fecal microbiota transplantation for the treatment of inflammatory bowel disease. Therap Adv Gastroenterol. 2019;12:1756284819836893. https:\/\/doi.org\/10.1177\/1756284819836893.","journal-title":"Therap Adv Gastroenterol"},{"issue":"2","key":"6527_CR170","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/mi.2016.123","volume":"10","author":"AH Keshteli","year":"2017","unstructured":"Keshteli AH, Millan B, Madsen KL. Pretreatment with antibiotics may enhance the efficacy of fecal microbiota transplantation in ulcerative colitis: a meta-analysis. Mucosal Immunol. 2017;10(2):565\u20136. https:\/\/doi.org\/10.1038\/mi.2016.123.","journal-title":"Mucosal Immunol"},{"issue":"8","key":"6527_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100711","volume":"3","author":"D Podlesny","year":"2022","unstructured":"Podlesny D, Durdevic M, Paramsothy S, et al. Identification of clinical and ecological determinants of strain engraftment after fecal microbiota transplantation using metagenomics. Cell Rep Med. 2022;3(8): 100711. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100711.","journal-title":"Cell Rep Med"},{"issue":"9","key":"6527_CR172","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s41591-022-01964-3","volume":"28","author":"G Ianiro","year":"2022","unstructured":"Ianiro G, Pun\u010doch\u00e1\u0159 M, Karcher N, et al. Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases. Nat Med. 2022;28(9):1913\u201323. https:\/\/doi.org\/10.1038\/s41591-022-01964-3.","journal-title":"Nat Med"},{"issue":"1","key":"6527_CR173","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41467-019-14177-z","volume":"11","author":"A Vich Vila","year":"2020","unstructured":"Vich Vila A, Collij V, Sanna S, et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun. 2020;11(1):362. https:\/\/doi.org\/10.1038\/s41467-019-14177-z.","journal-title":"Nat Commun"},{"issue":"8","key":"6527_CR174","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","volume":"69","author":"RK Weersma","year":"2020","unstructured":"Weersma RK, Zhernakova A, Fu J. Interaction between drugs and the gut microbiome. Gut. 2020;69(8):1510\u20139. https:\/\/doi.org\/10.1136\/gutjnl-2019-320204.","journal-title":"Gut"},{"issue":"7698","key":"6527_CR175","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","volume":"555","author":"L Maier","year":"2018","unstructured":"Maier L, Pruteanu M, Kuhn M, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018;555(7698):623\u20138. https:\/\/doi.org\/10.1038\/nature25979.","journal-title":"Nature"},{"issue":"732","key":"6527_CR176","doi-asserted-by":"publisher","first-page":"eadg8357","DOI":"10.1126\/scitranslmed.adg8357","volume":"16","author":"AA Verdegaal","year":"2024","unstructured":"Verdegaal AA, Goodman AL. Integrating the gut microbiome and pharmacology. Sci Transl Med. 2024;16(732):eadg8357. https:\/\/doi.org\/10.1126\/scitranslmed.adg8357.","journal-title":"Sci Transl Med."},{"issue":"4","key":"6527_CR177","doi-asserted-by":"publisher","first-page":"A414","DOI":"10.1016\/S0016-5085(00)83765-8","volume":"118","author":"M Pimentel","year":"2000","unstructured":"Pimentel M, Hallegua D, Chow EJ, Wallace D, Bonorris G, Lin HC. Eradication of small intestinal bacterial overgrowth decreases symptoms in chronic fatigue syndrome: a double blind, randomized study. Gastroenterology. 2000;118(4):A414. https:\/\/doi.org\/10.1016\/S0016-5085(00)83765-8.","journal-title":"Gastroenterology"},{"issue":"11","key":"6527_CR178","doi-asserted-by":"publisher","first-page":"e00395","DOI":"10.1128\/AEM.00395-21","volume":"87","author":"S Wei","year":"2021","unstructured":"Wei S, Bahl MI, Baunwall SM, Hvas CL, Licht TR. Determining gut microbial dysbiosis: a review of applied indexes for assessment of intestinal microbiota imbalances. Appl Environ Microbiol. 2021;87(11):e00395-e421. https:\/\/doi.org\/10.1128\/AEM.00395-21.","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"6527_CR179","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrmicro2536","volume":"9","author":"BP Willing","year":"2011","unstructured":"Willing BP, Russell SL, Finlay BB. Shifting the balance: antibiotic effects on host\u2013microbiota mutualism. Nat Rev Microbiol. 2011;9(4):233\u201343. https:\/\/doi.org\/10.1038\/nrmicro2536.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"6527_CR180","doi-asserted-by":"publisher","first-page":"725","DOI":"10.55006\/biolsciences.2024.4307","volume":"4","author":"M Abdulsalam","year":"2024","unstructured":"Abdulsalam M, Hamisu AA, Ahmad AM, Wakili FB, Annu FS, Garba MM. Microbiome dynamics and strategic management strategies: exploring synergies between integrative medicine modalities and microbial balance. Biol Sci. 2024;4(3):725\u201335. https:\/\/doi.org\/10.55006\/biolsciences.2024.4307.","journal-title":"Biol Sci"},{"issue":"1","key":"6527_CR181","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/biomedicines12010194","volume":"12","author":"S Wang","year":"2024","unstructured":"Wang S, Ju D, Zeng X. Mechanisms and clinical implications of human gut microbiota-drug interactions in the precision medicine era. Biomedicines. 2024;12(1):194. https:\/\/doi.org\/10.3390\/biomedicines12010194.","journal-title":"Biomedicines"},{"issue":"5","key":"6527_CR182","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3390\/metabo13050674","volume":"13","author":"S Mousa","year":"2023","unstructured":"Mousa S, Sarfraz M, Mousa WK. The interplay between gut microbiota and oral medications and its impact on advancing precision medicine. Metabolites. 2023;13(5):674. https:\/\/doi.org\/10.3390\/metabo13050674.","journal-title":"Metabolites"},{"issue":"1","key":"6527_CR183","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41392-023-01619-w","volume":"8","author":"Q Zhao","year":"2023","unstructured":"Zhao Q, Chen Y, Huang W, Zhou H, Zhang W. Drug-microbiota interactions: an emerging priority for precision medicine. Signal Transduct Target Ther. 2023;8(1):386. https:\/\/doi.org\/10.1038\/s41392-023-01619-w.","journal-title":"Signal Transduct Target Ther"},{"key":"6527_CR184","doi-asserted-by":"publisher","first-page":"goac009","DOI":"10.1093\/gastro\/goac009","volume":"10","author":"ZT WanY","year":"2022","unstructured":"WanY ZT. Interplays between drugs and the gut microbiome. Gastroenterol Rep. 2022;10:goac009. https:\/\/doi.org\/10.1093\/gastro\/goac009.","journal-title":"Gastroenterol Rep"},{"key":"6527_CR185","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3389\/fphar.2020.01153","volume":"11","author":"D Maseda","year":"2020","unstructured":"Maseda D, Ricciotti E. NSAID\u2013gut microbiota interactions. Front Pharmacol. 2020;11:1153. https:\/\/doi.org\/10.3389\/fphar.2020.01153.","journal-title":"Front Pharmacol"},{"issue":"4","key":"6527_CR186","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/JCP.0b013e318225848c","volume":"31","author":"TC Theoharides","year":"2011","unstructured":"Theoharides TC, Asadi S, Weng Z, Zhang B. Serotonin-selective reuptake inhibitors and nonsteroidal anti-inflammatory drugs-important considerations of adverse interactions especially for the treatment of myalgic encephalomyelitis\/chronic fatigue syndrome. J Clin Psychopharmacol. 2011;31(4):403\u20135. https:\/\/doi.org\/10.1097\/JCP.0b013e318225848c.","journal-title":"J Clin Psychopharmacol"},{"issue":"9","key":"6527_CR187","doi-asserted-by":"publisher","first-page":"643","DOI":"10.4088\/jcp.v61n0909","volume":"61","author":"IB Hickie","year":"2000","unstructured":"Hickie IB, Wilson AJ, Wright JM, Bennett BK, Wakefield D, Lloyd AR. A randomized, double-blind, placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome. J Clin Psychiatry. 2000;61(9):643\u20138. https:\/\/doi.org\/10.4088\/jcp.v61n0909.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"6527_CR188","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/BF02246661","volume":"124","author":"BH Natelson","year":"1996","unstructured":"Natelson BH, Pareja J, Policastro T, Cheu J, Ellis SP, Findley TW. Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome. Psychopharmacology. 1996;124(3):226\u201330. https:\/\/doi.org\/10.1007\/BF02246661.","journal-title":"Psychopharmacology"},{"issue":"1","key":"6527_CR189","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.pnpbp.2007.07.019","volume":"32","author":"JD Amsterdam","year":"2008","unstructured":"Amsterdam JD, Shults J, Rutherford N. Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(1):100\u20136. https:\/\/doi.org\/10.1016\/j.pnpbp.2007.07.019.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"9005","key":"6527_CR190","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/s0140-6736(96)91345-8","volume":"347","author":"JH Vercoulen","year":"1996","unstructured":"Vercoulen JH, Hoofs MP, Bleijenberg G, et al. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet. 1996;347(9005):858\u201361. https:\/\/doi.org\/10.1016\/s0140-6736(96)91345-8.","journal-title":"Lancet"},{"key":"6527_CR191","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1192\/bjp.172.6.485","volume":"172","author":"AJ Wearden","year":"1998","unstructured":"Wearden AJ, Morriss RK, Mullis R, et al. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatry. 1998;172:485\u201390. https:\/\/doi.org\/10.1192\/bjp.172.6.485.","journal-title":"Br J Psychiatry"},{"issue":"3","key":"6527_CR192","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.psym.2014.12.003","volume":"56","author":"LM Arnold","year":"2015","unstructured":"Arnold LM, Blom TJ, Welge JA, Mariutto E, Heller A. A randomized, placebo-controlled, double-blinded trial of duloxetine in the treatment of general fatigue in patients with chronic fatigue syndrome. Psychosomatics. 2015;56(3):242\u201353. https:\/\/doi.org\/10.1016\/j.psym.2014.12.003.","journal-title":"Psychosomatics"},{"issue":"12","key":"6527_CR193","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1177\/0004867419877954","volume":"53","author":"AS McGovern","year":"2019","unstructured":"McGovern AS, Hamlin AS, Winter G. A review of the antimicrobial side of antidepressants and its putative implications on the gut microbiome. Aust N Z J Psychiatry. 2019;53(12):1151\u201366. https:\/\/doi.org\/10.1177\/0004867419877954.","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"6527_CR194","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41398-021-01254-5","volume":"11","author":"W Zhang","year":"2021","unstructured":"Zhang W, Qu W, Wang H, Yan H. Antidepressants fluoxetine and amitriptyline induce alterations in intestinal microbiota and gut microbiome function in rats exposed to chronic unpredictable mild stress. Transl Psychiatry. 2021;11(1):131. https:\/\/doi.org\/10.1038\/s41398-021-01254-5.","journal-title":"Transl Psychiatry"},{"key":"6527_CR195","doi-asserted-by":"publisher","first-page":"1132403","DOI":"10.3389\/fmicb.2023.1132403","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, Qu W, Hu C, Liu Z, Yan H. Antidepressants amitriptyline, fluoxetine, and traditional Chinese medicine Xiaoyaosan caused alterations in gut DNA virome composition and function in rats exposed chronic unpredictable mild stress. Front Microbiol. 2023;14:1132403. https:\/\/doi.org\/10.3389\/fmicb.2023.1132403.","journal-title":"Front Microbiol"},{"key":"6527_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpc.2022.109417","volume":"260","author":"Y Shi","year":"2022","unstructured":"Shi Y, Chen C, Wu X, et al. Exposure to amitriptyline induces persistent gut damages and dysbiosis of the gut microbiota in zebrafish (Danio rerio). Comp Biochem Physiol C Toxicol Pharmacol. 2022;260: 109417. https:\/\/doi.org\/10.1016\/j.cbpc.2022.109417.","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"issue":"5","key":"6527_CR197","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.21873\/invivo.12939","volume":"36","author":"K Ninomiya","year":"2022","unstructured":"Ninomiya K, Paudel D, Uehara O, et al. Effect of systemic administration of amitriptyline on oral microbes in rats. In Vivo. 2022;36(5):2134\u201342. https:\/\/doi.org\/10.21873\/invivo.12939.","journal-title":"In Vivo"},{"issue":"1","key":"6527_CR198","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1067\/moe.2000.107363","volume":"90","author":"SB Woo","year":"2000","unstructured":"Woo SB, Schacterle RS, Komaroff AL, Gallagher GT. Salivary gland changes in chronic fatigue syndrome: a case-controlled preliminary histologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(1):82\u20137. https:\/\/doi.org\/10.1067\/moe.2000.107363.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"16","key":"6527_CR199","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.3390\/jcm10163675","volume":"10","author":"H Freitag","year":"2021","unstructured":"Freitag H, Szklarski M, Lorenz S, et al. Autoantibodies to vasoregulative G-protein-coupled receptors correlate with symptom severity, autonomic dysfunction and disability in myalgic encephalomyelitis\/chronic fatigue syndrome. J Clin Med. 2021;10(16):3675. https:\/\/doi.org\/10.3390\/jcm10163675.","journal-title":"J Clin Med"},{"key":"6527_CR200","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2023.100720","volume":"36","author":"A Gil","year":"2023","unstructured":"Gil A, Hoag GE, Salerno JP, Hornig M, Klimas N, Selin LK. Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and Long COVID and treatment with a nebulized antioxidant\/anti-pathogen agent in a retrospective case series. Brain Behav Immun Health. 2023;36: 100720. https:\/\/doi.org\/10.1016\/j.bbih.2023.100720.","journal-title":"Brain Behav Immun Health"},{"key":"6527_CR201","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.578386","volume":"12","author":"F Cristofori","year":"2021","unstructured":"Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R. Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body. Front Immunol. 2021;12: 578386. https:\/\/doi.org\/10.3389\/fimmu.2021.578386.","journal-title":"Front Immunol"},{"issue":"2","key":"6527_CR202","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/biomedicines11020294","volume":"11","author":"C Campbell","year":"2023","unstructured":"Campbell C, Kandalgaonkar MR, Golonka RM, Yeoh BS, Vijay-Kumar M, Saha P. Crosstalk between gut microbiota and host immunity: impact on inflammation and immunotherapy. Biomedicines. 2023;11(2):294. https:\/\/doi.org\/10.3390\/biomedicines11020294.","journal-title":"Biomedicines"},{"key":"6527_CR203","doi-asserted-by":"publisher","first-page":"1355542","DOI":"10.3389\/fnut.2024.1355542","volume":"11","author":"P Zhou","year":"2024","unstructured":"Zhou P, Chen C, Patil S, Dong S. Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony. Front Nutr. 2024;11:1355542. https:\/\/doi.org\/10.3389\/fnut.2024.1355542.","journal-title":"Front Nutr"},{"key":"6527_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2022.101691","volume":"65","author":"Z Wang","year":"2022","unstructured":"Wang Z, Wang Z, Lu T, et al. The microbiota-gut-brain axis in sleep disorders. Sleep Med Rev. 2022;65: 101691. https:\/\/doi.org\/10.1016\/j.smrv.2022.101691.","journal-title":"Sleep Med Rev"},{"issue":"11","key":"6527_CR205","doi-asserted-by":"publisher","first-page":"9603","DOI":"10.3390\/ijms24119603","volume":"24","author":"J Sun","year":"2023","unstructured":"Sun J, Fang D, Wang Z, Liu Y. Sleep deprivation and gut microbiota dysbiosis: current understandings and implications. Int J Mol Sci. 2023;24(11):9603. https:\/\/doi.org\/10.3390\/ijms24119603.","journal-title":"Int J Mol Sci"},{"key":"6527_CR206","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sleep.2021.08.003","volume":"87","author":"B Neroni","year":"2021","unstructured":"Neroni B, Evangelisti M, Radocchia G, et al. Relationship between sleep disorders and gut dysbiosis: what affects what? Sleep Med. 2021;87:1\u20137. https:\/\/doi.org\/10.1016\/j.sleep.2021.08.003.","journal-title":"Sleep Med"},{"key":"6527_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2020.101340","volume":"53","author":"BA Matenchuk","year":"2020","unstructured":"Matenchuk BA, Mandhane PJ, Kozyrskyj AL. Sleep, circadian rhythm, and gut microbiota. Sleep Med Rev. 2020;53: 101340. https:\/\/doi.org\/10.1016\/j.smrv.2020.101340.","journal-title":"Sleep Med Rev"},{"issue":"12","key":"6527_CR208","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.molmet.2016.10.003","volume":"5","author":"C Benedict","year":"2016","unstructured":"Benedict C, Vogel H, Jonas W, et al. Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals. Mol Metab. 2016;5(12):1175\u201386. https:\/\/doi.org\/10.1016\/j.molmet.2016.10.003.","journal-title":"Mol Metab"},{"issue":"4","key":"6527_CR209","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12399","volume":"62","author":"P Xu","year":"2017","unstructured":"Xu P, Wang J, Hong F, et al. Melatonin prevents obesity through modulation of gut microbiota in mice. J Pineal Res. 2017;62(4): e12399. https:\/\/doi.org\/10.1111\/jpi.12399.","journal-title":"J Pineal Res"},{"key":"6527_CR210","doi-asserted-by":"publisher","first-page":"35405","DOI":"10.1038\/srep35405","volume":"6","author":"VA Poroyko","year":"2016","unstructured":"Poroyko VA, Carreras A, Khalyfa A, et al. Chronic sleep disruption alters gut microbiota, induces systemic and adipose tissue inflammation and insulin resistance in mice. Sci Rep. 2016;6:35405. https:\/\/doi.org\/10.1038\/srep35405.","journal-title":"Sci Rep"},{"issue":"2","key":"6527_CR211","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229001","volume":"15","author":"SJ Bowers","year":"2020","unstructured":"Bowers SJ, Vargas F, Gonz\u00e1lez A, et al. Repeated sleep disruption in mice leads to persistent shifts in the fecal microbiome and metabolome. PLoS ONE. 2020;15(2): e0229001. https:\/\/doi.org\/10.1371\/journal.pone.0229001.","journal-title":"PLoS ONE"},{"issue":"10","key":"6527_CR212","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222394","volume":"14","author":"RP Smith","year":"2019","unstructured":"Smith RP, Easson C, Lyle SM, et al. Gut microbiome diversity is associated with sleep physiology in humans. PLoS ONE. 2019;14(10): e0222394. https:\/\/doi.org\/10.1371\/journal.pone.0222394.","journal-title":"PLoS ONE"},{"key":"6527_CR213","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.3389\/fmicb.2019.01770","volume":"10","author":"B Liu","year":"2019","unstructured":"Liu B, Lin W, Chen S, et al. Gut microbiota as an objective measurement for auxiliary diagnosis of insomnia disorder. Front Microbiol. 2019;10:1770. https:\/\/doi.org\/10.3389\/fmicb.2019.01770.","journal-title":"Front Microbiol"},{"issue":"3","key":"6527_CR214","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.cell.2014.09.048","volume":"159","author":"CA Thaiss","year":"2014","unstructured":"Thaiss CA, Zeevi D, Levy M, et al. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell. 2014;159(3):514\u201329. https:\/\/doi.org\/10.1016\/j.cell.2014.09.048.","journal-title":"Cell"},{"issue":"1","key":"6527_CR215","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3184\/003685009X12605525292307","volume":"93","author":"P Louis","year":"2010","unstructured":"Louis P, O\u2019byrne CP. Life in the gut: microbial responses to stress in the gastrointestinal tract. Sci Prog. 2010;93(1):7\u201336. https:\/\/doi.org\/10.3184\/003685009X12605525292307.","journal-title":"Sci Prog"},{"issue":"1","key":"6527_CR216","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/pr.2014.49","volume":"76","author":"L Putignani","year":"2014","unstructured":"Putignani L, Del Chierico F, Petrucca A, Vernocchi P, Dallapiccola B. The human gut microbiota: a dynamic interplay with the host from birth to senescence settled during childhood. Pediatr Res. 2014;76(1):2\u201310. https:\/\/doi.org\/10.1038\/pr.2014.49.","journal-title":"Pediatr Res"},{"issue":"6","key":"6527_CR217","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.anai.2014.08.020","volume":"113","author":"NH Salzman","year":"2014","unstructured":"Salzman NH. The role of the microbiome in immune cell development. Ann Allergy Asthma Immunol. 2014;113(6):593\u20138. https:\/\/doi.org\/10.1016\/j.anai.2014.08.020.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"6527_CR218","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/microorganisms7080271","volume":"7","author":"S Lobionda","year":"2019","unstructured":"Lobionda S, Sittipo P, Kwon HY, Lee YK. The role of gut microbiota in intestinal inflammation with respect to diet and extrinsic stressors. Microorganisms. 2019;7(8):271. https:\/\/doi.org\/10.3390\/microorganisms7080271.","journal-title":"Microorganisms"},{"issue":"3","key":"6527_CR219","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10787-014-0201-4","volume":"22","author":"L Vitetta","year":"2014","unstructured":"Vitetta L, Briskey D, Alford H, Hall S, Coulson S. Probiotics, prebiotics and the gastrointestinal tract in health and disease. Inflammopharmacology. 2014;22(3):135\u201354. https:\/\/doi.org\/10.1007\/s10787-014-0201-4.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"6527_CR220","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12964-022-00880-w","volume":"20","author":"RN Mohammed","year":"2022","unstructured":"Mohammed RN, Khosravi M, Rahman HS, et al. Anastasis: cell recovery mechanisms and potential role in cancer. Cell Commun Signal. 2022;20(1):81. https:\/\/doi.org\/10.1186\/s12964-022-00880-w.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"6527_CR221","doi-asserted-by":"publisher","first-page":"13690","DOI":"10.4081\/ejtm.2025.13690","volume":"35","author":"AA El-Sehrawy","year":"2025","unstructured":"El-Sehrawy AA, Ayoub II, Uthirapathy S, et al. The microbiota-gut-brain axis in myalgic encephalomyelitis\/chronic fatigue syndrome: a narrative review of an emerging field. Eur J Transl Myol. 2025;35(1):13690. https:\/\/doi.org\/10.4081\/ejtm.2025.13690.","journal-title":"Eur J Transl Myol"},{"issue":"10092","key":"6527_CR222","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0140-6736(16)32589-2","volume":"390","author":"LV Clark","year":"2017","unstructured":"Clark LV, Pesola F, Thomas JM, Vergara-Williamson M, Beynon M, White PD. Guided graded exercise self-help plus specialist medical care versus specialist medical care alone for chronic fatigue syndrome (GETSET): a pragmatic randomised controlled trial. Lancet. 2017;390(10092):363\u201373. https:\/\/doi.org\/10.1016\/S0140-6736(16)32589-2.","journal-title":"Lancet"},{"issue":"10","key":"6527_CR223","doi-asserted-by":"publisher","first-page":"CD003200","DOI":"10.1002\/14651858.CD003200.pub8","volume":"10","author":"L Larun","year":"2019","unstructured":"Larun L, Brurberg KG, Odgaard-Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev. 2019;10(10):CD003200. https:\/\/doi.org\/10.1002\/14651858.CD003200.pub8.","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"6527_CR224","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.4045\/tidsskr.09.35791","volume":"129","author":"T Bj\u00f8rkum","year":"2009","unstructured":"Bj\u00f8rkum T, Wang CE. Patients\u2019 experience with treatment of chronic fatigue syndrome. Tidsskr Nor Laegeforen. 2009;129(12):1214\u20136. https:\/\/doi.org\/10.4045\/tidsskr.09.35791.","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"9768","key":"6527_CR225","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0140-6736(11)60096-2","volume":"377","author":"PD White","year":"2011","unstructured":"White PD, Goldsmithb KA, Johnson AL, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomized trial. Lancet. 2011;377(9768):823\u201336. https:\/\/doi.org\/10.1016\/S0140-6736(11)60096-2.","journal-title":"Lancet"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06527-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06527-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06527-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T08:48:55Z","timestamp":1746953335000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06527-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,11]]},"references-count":225,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6527"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06527-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,11]]},"assertion":[{"value":"15 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they had no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"530"}}